Advertisement
KALA vs LRMR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALA is a Hold and LRMR is a Hold.
KALA sees MACD Histogram crosses below signal line
KALA saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 02, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In 36 of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KALA as a result. In 65 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KALA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for KALA entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where KALA advanced for three days, in 167 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
KALA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.963) is normal, around the industry mean (26.782). P/E Ratio (11.062) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. KALA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KALA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for LRMR turns negative, indicating new downward trend
LRMR saw its Momentum Indicator move below the 0 level on September 22, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In 86 of the 92 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day moving average for LRMR crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for LRMR moved below the 200-day moving average on September 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LRMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for LRMR entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where LRMR advanced for three days, in 217 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
LRMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.585) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. LRMR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LRMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
KALA | LRMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 25 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 98 | 93 | |
P/E GROWTH RATING 1..100 | 97 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 42 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LRMR's Valuation (25) in the null industry is somewhat better than the same rating for KALA (64) in the Pharmaceuticals Major industry. This means that LRMR’s stock grew somewhat faster than KALA’s over the last 12 months.
LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that LRMR’s stock grew similarly to KALA’s over the last 12 months.
LRMR's SMR Rating (100) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that LRMR’s stock grew similarly to KALA’s over the last 12 months.
LRMR's Price Growth Rating (93) in the null industry is in the same range as KALA (98) in the Pharmaceuticals Major industry. This means that LRMR’s stock grew similarly to KALA’s over the last 12 months.
KALA's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as LRMR (100) in the null industry. This means that KALA’s stock grew similarly to LRMR’s over the last 12 months.
| KALA | LRMR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 88% | 1 day ago 88% |
| Momentum ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | N/A |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 25 days ago 80% | about 1 month ago 84% |
| Declines ODDS (%) | 3 days ago 90% | 1 day ago 89% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KALA’s FA Score shows that 0 FA rating(s) are green while LRMR’s FA Score has 1 green FA rating(s).
- KALA’s FA Score: 0 green, 5 red.
- LRMR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KALA’s TA Score shows that 4 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).
- KALA’s TA Score: 4 bullish, 4 bearish.
- LRMR’s TA Score: 4 bullish, 5 bearish.
Price Growth
KALA (@Biotechnology) experienced а -34.25% price change this week, while LRMR (@Biotechnology) price change was -26.30% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -7.32%. For the same industry, the average monthly price growth was -15.10%, and the average quarterly price growth was -18.48%.
Reported Earning Dates
LRMR is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-7.32% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBFR | 31.46 | 0.04 | +0.13% |
| PGIM Laddered S&P 500 Buffer 20 ETF (PBFR) | |||
| FARX | 29.96 | -0.09 | -0.31% |
| Frontier Asset Absolute Return ETF | |||
| FTEC | 292.00 | -1.08 | -0.37% |
| Fidelity MSCI Information Technology Index ETF (FTEC) | |||
| CMDT | 32.15 | -0.13 | -0.42% |
| PIMCO Commodity Strategy Active Exchange-Traded Fund (CMDT) | |||
| FFEM | 39.71 | -0.30 | -0.75% |
| Fidelity Fundamental Emerging Markets ETF | |||
KALA and
Correlation & Price change
A.I.dvisor indicates that over the last year, KALA has been closely correlated with MLTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if KALA jumps, then MLTX could also see price increases.
| Ticker / NAME | Correlation To KALA | 1D Price Change % | ||
|---|---|---|---|---|
| KALA | 100% | +3.72% | ||
| MLTX - KALA | 82% Closely correlated | +1.18% | ||
| LRMR - KALA | 38% Loosely correlated | -4.78% | ||
| CLRB - KALA | 34% Loosely correlated | +0.85% | ||
| PALI - KALA | 31% Poorly correlated | +4.05% | ||
| OVID - KALA | 29% Poorly correlated | +3.20% | ||
More | ||||
LRMR and
Correlation & Price change
A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with AMLX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then AMLX could also see price increases.
| Ticker / NAME | Correlation To LRMR | 1D Price Change % | ||
|---|---|---|---|---|
| LRMR | 100% | -4.78% | ||
| AMLX - LRMR | 45% Loosely correlated | +2.29% | ||
| CLDX - LRMR | 42% Loosely correlated | +3.93% | ||
| MLTX - LRMR | 42% Loosely correlated | +1.18% | ||
| VIR - LRMR | 42% Loosely correlated | +0.58% | ||
| REPL - LRMR | 40% Loosely correlated | +3.16% | ||
More | ||||